Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
After 12 days in D:D conditions mice are injected with a single dose of SR9011 or vehicle at CT6 (peak expression of Rev-erbα)
and SUN concentrations and renal caspase 3/7 activity decreased in 5/6Nx mice treated with NS-03-08
No significant weight loss occurs in cambinol-treated animals relative to controls
Resolvin D1 blocks proinflammatory neutrophil migration by regulating actin polymerization
Activator of epithelial KCa channels
Ranolazine-d8 H-PEG4-CH2COOH After 12 days in D:DRanolazine d8 (CVT 303 d8) is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 M and 12 M, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor. Antianginal agent. Product information CAS Number: 1092804 88 0 Molecular Weight: 435.
US$ 102.50
US$ 106.99
US$ 199.99
US$ 24.89
US$ 80.00